AbstractIntroductionHemodialysis Reliable Outflow (HeRO) (Hemosphere Inc, Minneapolis, MN, USA) vascular access device is a new long-term subcutaneous access designed for patients who have exhausted traditional peripheral access sites.ReportWe describe the use of the HeRO device not to create new access but to resolve symptoms of venous hypertension and salvage still functional arteriovenous fistula (AVF) in a patient refractory to endovascular treatment of recurrent central venous occlusive disease (CVOD).ConclusionThis report reinforces the experience of other authors that the HeRO device is an effective means to salvage an AV access and relieve symptoms of venous hypertension
BackgroundArteriovenous fistulas (AVFs) are recommended for hemodialysis access when possible. A non...
© 2020 Since the arteriovenous fistula (AVF) was first conceived over 50 years ago, the goal to crea...
<div><p>Vascular access for dialysis is essential for these patients with end-stage renal disease, i...
AbstractIntroductionHemodialysis Reliable Outflow (HeRO) (Hemosphere Inc, Minneapolis, MN, USA) vasc...
The Hemodialysis Reliable Outflow (HeRO) graft (Hemosphere Inc, Eden Prairie, Minn) offers a new opt...
ObjectivesWith improved dialysis survival there are increasing numbers of patients who have exhauste...
ObjectiveThe effects of a new long-term subcutaneous vascular access device were studied in access-c...
Objectives: With improved dialysis survival there are increasing numbers of patients who have exhaus...
A modified technique for placement of the venous outflow component (VOC) of the Hemodialysis Reliabl...
AbstractIntroductionThis case report intends to highlight the Haemodialysis Reliable Outflow (HeRO) ...
Introduction: Venous hypertension (VH) is a distressing complication following the creation of arter...
After creation of an arteriovenous fistula or placement of an arteriovenous graft, several weeks are...
Introduction: This case report intends to highlight the Haemodialysis Reliable Outflow (HeRO) graft ...
In hemodialysis, vascular access is a key issue. The preferred access is an arteriovenous fistula on...
Although more challenging to place, the HeRO device (Hemosphere Inc, Eden Prairie, Minn) provides th...
BackgroundArteriovenous fistulas (AVFs) are recommended for hemodialysis access when possible. A non...
© 2020 Since the arteriovenous fistula (AVF) was first conceived over 50 years ago, the goal to crea...
<div><p>Vascular access for dialysis is essential for these patients with end-stage renal disease, i...
AbstractIntroductionHemodialysis Reliable Outflow (HeRO) (Hemosphere Inc, Minneapolis, MN, USA) vasc...
The Hemodialysis Reliable Outflow (HeRO) graft (Hemosphere Inc, Eden Prairie, Minn) offers a new opt...
ObjectivesWith improved dialysis survival there are increasing numbers of patients who have exhauste...
ObjectiveThe effects of a new long-term subcutaneous vascular access device were studied in access-c...
Objectives: With improved dialysis survival there are increasing numbers of patients who have exhaus...
A modified technique for placement of the venous outflow component (VOC) of the Hemodialysis Reliabl...
AbstractIntroductionThis case report intends to highlight the Haemodialysis Reliable Outflow (HeRO) ...
Introduction: Venous hypertension (VH) is a distressing complication following the creation of arter...
After creation of an arteriovenous fistula or placement of an arteriovenous graft, several weeks are...
Introduction: This case report intends to highlight the Haemodialysis Reliable Outflow (HeRO) graft ...
In hemodialysis, vascular access is a key issue. The preferred access is an arteriovenous fistula on...
Although more challenging to place, the HeRO device (Hemosphere Inc, Eden Prairie, Minn) provides th...
BackgroundArteriovenous fistulas (AVFs) are recommended for hemodialysis access when possible. A non...
© 2020 Since the arteriovenous fistula (AVF) was first conceived over 50 years ago, the goal to crea...
<div><p>Vascular access for dialysis is essential for these patients with end-stage renal disease, i...